These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35031171)

  • 1. Cardiovascular Toxicity Due to Otilonium Bromide Overdose: A Case Report.
    Zaki SA; Helal ME; Rashid A
    J Emerg Med; 2022 Mar; 62(3):e47-e50. PubMed ID: 35031171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome.
    Evangelista S
    Curr Pharm Des; 2004; 10(28):3561-8. PubMed ID: 15579053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
    Clavé P; Acalovschi M; Triantafillidis JK; Uspensky YP; Kalayci C; Shee V; Tack J;
    Aliment Pharmacol Ther; 2011 Aug; 34(4):432-42. PubMed ID: 21679214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromide.
    Forte E; Pizzoferrato M; Lopetuso L; Scaldaferri F
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):25-37. PubMed ID: 22338545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended analysis of a double-blind, placebo-controlled, 15-week study with otilonium bromide in irritable bowel syndrome.
    Glende M; Morselli-Labate AM; Battaglia G; Evangelista S
    Eur J Gastroenterol Hepatol; 2002 Dec; 14(12):1331-8. PubMed ID: 12468954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irritable bowel syndrome: focus on otilonium bromide.
    Boeckxstaens G; Clavé P; Corazziari ES; Tack J
    Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):131-7. PubMed ID: 24417261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimuscarinic, calcium channel blocker and tachykinin NK2 receptor antagonist actions of otilonium bromide in the circular muscle of guinea-pig colon.
    Santicioli P; Zagorodnyuk V; Renzetti AR; Maggi CA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 May; 359(5):420-7. PubMed ID: 10498293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study.
    Battaglia G; Morselli-Labate AM; Camarri E; Francavilla A; De Marco F; Mastropaolo G; Naccarato R
    Aliment Pharmacol Ther; 1998 Oct; 12(10):1003-10. PubMed ID: 9798806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of herbal extract granules combined with otilonium bromide on irritable bowel syndrome with diarrhoea: a study protocol for a randomised controlled trial.
    Kim JI; Kim P; Lee JH; Kim YJ; Yang NR; Baeg MK; Choi JS; Kim HJ; Kim J; Sunwoo YY; Lee JH; Ha H; Park TY
    BMJ Open; 2017 Dec; 7(11):e018362. PubMed ID: 29196484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irritable bowel syndrome.
    Spinelli A
    Clin Drug Investig; 2007; 27(1):15-33. PubMed ID: 17177577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is otilonium bromide globally effective in irritable bowel syndrome?
    Desborough MJ; Ford AC
    Aliment Pharmacol Ther; 2011 Oct; 34(8):1034-5; author reply 1035-6. PubMed ID: 21933208
    [No Abstract]   [Full Text] [Related]  

  • 12. Irritable Bowel Syndrome Therapeutic Has Broad-Spectrum Antimicrobial Activity.
    Cunningham AL; Esarte Palomero O; Voss BJ; Trent MS; Davies BW
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0044321. PubMed ID: 34280019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Otilonium bromide enhances sensory thresholds of volume and pressure in patients with irritable bowel syndrome.
    Czimmer J; Süto G; Király A; Mózsik G
    J Physiol Paris; 2001; 95(1-6):153-6. PubMed ID: 11595430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Otilonium bromide inhibits calcium entry through L-type calcium channels in human intestinal smooth muscle.
    Strege PR; Evangelista S; Lyford GL; Sarr MG; Farrugia G
    Neurogastroenterol Motil; 2004 Apr; 16(2):167-73. PubMed ID: 15086870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IBS and the role of otilonium bromide.
    Boeckxstaens G; Corazziari ES; Mearin F; Tack J
    Int J Colorectal Dis; 2013 Mar; 28(3):295-304. PubMed ID: 23178991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Otilonium bromide - challenges of putting trial data into practice.
    Hungin AP
    Aliment Pharmacol Ther; 2011 Oct; 34(8):1030; author reply 1031. PubMed ID: 21933204
    [No Abstract]   [Full Text] [Related]  

  • 17. Otilonium bromide in irritable bowel syndrome: a dose-ranging randomized double-blind placebo-controlled trial.
    Chmielewska-Wilkoń D; Reggiardo G; Egan CG
    World J Gastroenterol; 2014 Sep; 20(34):12283-91. PubMed ID: 25232263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of spasmolytic agent otilonium bromide (spasmomen) in digestive endoscopy: a prospective study in 63 patients].
    Gómez NA; León CJ; Gutiérrez J
    Acta Gastroenterol Latinoam; 1997; 27(3):123-5. PubMed ID: 9412140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antispasmodics in the treatment of irritable bowel syndrome.
    Annaházi A; Róka R; Rosztóczy A; Wittmann T
    World J Gastroenterol; 2014 May; 20(20):6031-43. PubMed ID: 24876726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased paracellular absorption by bile salts and P-glycoprotein stimulated efflux of otilonium bromide in Caco-2 cells monolayers as a model of intestinal barrier.
    Catalioto RM; Triolo A; Giuliani S; Altamura M; Evangelista S; Maggi CA
    J Pharm Sci; 2008 Sep; 97(9):4087-100. PubMed ID: 18200532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.